This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
News & Press: Association News

AVA Foundation to Fund miniMAGIC

Monday, March 26, 2018  
Share |



AVA Foundation to Fund Creation and Development of Michigan Appropriateness Guide for Infusion Catheters in Pediatric Patients (miniMAGIC)


March 26, 2018 - Today the Association for Vascular Access (AVA) Foundation announced funding for a major innovative research project intended to improve pediatric vascular access outcomes.


The initiative will be led by Amanda Ullman, RN, MAppSci, PhD, of Griffith University, with support from Vineet Chopra, MD, MSc from the University of Michigan and their respective teams. The goal of the project is to develop a novel pediatrics algorithm that produces evidence-based recommendations for when a particular vascular access device is appropriate for use.


“This collaboration aims to provide healthcare professionals with an evidence and expert-based criteria for the selection of infusion catheters, including vascular access devices (VADs) in pediatrics across Australia and the United States,” Dr. Ullman said. “Currently, no standardized decision-making process exists for the selection of these devices in pediatric patients.”


As a result, the uncoordinated approach to VAD decision-making often leads to inappropriate devices being inserted, which results in significant, preventable harm to vascular access dependent children and inefficient treatment outcomes.


The Michigan Appropriateness Guide for Intravascular Catheters (MAGIC) algorithm (spearheaded by Chopra in 2015) covers the most commonly used IV devices, indications, patient types and settings for use. MAGIC criteria are based on 660 scenarios of different patient types and treatments, and uses both color-coded charts and algorithms to direct clinicians to which devices are suitable or suboptimal for each presentation.


This collaboration, dubbed miniMAGIC, will use the same approach to provide similar guidance for pediatric clinicians. It heralds a renewed focus on vascular access stewardship, which is important for children who may be VAD-dependent for their lifetime.


“We anticipate that miniMAGIC will drastically change national and international VAD decision-making practice, to prevent harm for this vulnerable population,” Dr. Ullman said.


“MAGIC has had a profound impact on informing decisions regarding vascular access in part because there was a large, unmet need for this type of resource,” Dr. Chopra said. “Our hope with this work is that we will be able to provide clear evidence-based guidance on which IV device is most appropriate for a pediatric population.”


Following a process that included critical review by the AVA Foundation Board of Directors, miniMAGIC marks the first major funding project approved by the Foundation and through the generous support of its membership, industry partners and AVA. The AVA Foundation is dedicated to saving lives through vascular access innovation, research and education. It serves clinicians interested in vascular access, students of the healthcare professions and vascular access patients and their families and is the nonprofit 501 (c)(3) arm of the Association for Vascular Access, which advances the vascular access specialty and defines its standards through evidence-based interventions to enhance healthcare and patient outcomes.


“The Foundation drives innovation, research and education across the vascular access continuum” AVA Foundation CEO Ramzy Nasrallah said. “Griffith University and the University of Michigan working collaboratively to develop miniMAGIC captures the entirety of what AVA and the Foundation pursue every day in protecting patients, educating clinicians and caring and maintaining intravascular catheters properly.”


The research is set to be presented at the AVA Scientific Meeting in Columbus, Ohio, in 2018 and again in 2019.


“Our expectation is that miniMAGIC will significantly improve patient outcomes, while serving as a flagship representation of how investment in the AVA Foundation can both positively and dramatically impact healthcare,” Nasrallah said. “We are confident that Dr. Ullman, Dr. Chopra and their teams will deliver profound evidence that will innovate how vascular access is delivered to children worldwide.”




Griffith University was established in 1971 and is among the premier public research institutions not only in Australia but the world. An Innovative Research University (IRU), Griffith offers a full slate of undergraduate, postgraduate and research curriculum for students. It has also become a comprehensive, research-intensive university, ranking in the top 3% of universities worldwide. Griffith’s teaching and research spans five campuses in Southeast Queensland and all disciplines, with a network of more than 200,000 graduates extending around the world

Michigan Medicine is home to one of the largest health care complexes in the world. It has been the site of many groundbreaking medical and technological advancements since the Medical School first opened in 1850. Its vision is to create the future of health care through discovery and to become the national leader in health care, health care reform, biomedical innovation and education.

The Association for Vascular Access (AVA) Foundation is dedicated to saving lives through risk-free vascular access by promoting evidence-based clinical practice. The Foundation serves clinicians interested in vascular access, students of the healthcare professions, and vascular access patients and their families. We are a not-for-profit, 501©(3) educational and research organization. To learn more or donate, visit or support the AVA Foundation by designating it as your favorite charitable organization when you shop at AmazonSmile.